1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ARS PHARMACEUTICALS INC
ARS Pharmaceuticals Inc
XNAS: SPRY

ARS Pharma Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intra...

Read More
8.74 -0.26 (-2.89%)
53.76% Fall from 52W High
1.3M
XNAS Volume

XNAS 08 May, 2026 4:17 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for ARS Pharma Inc is on 14 May 2026 for the purpose of ARS Pharmaceuticals Inc First Quarter Earnings Results for 2026 See details
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
10.0 / 100
Momentum Score
Technically Neutral
49.6 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
26
1Yr Price target upside is 199%
6 analysts

8

S

13

W

6

O

0

T

SWOT Analysis

ARS Pharma Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..